Loading…
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company provides specialized medical services as private practice. Founded/registered in 2007.
| Ratio | 2018 | 2019 | 2020 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 92.2% | 75.9% | 76.2% | 76.6% | 76.2% |
| EBITDA Margin | 8.3% | 12.4% | 21.3% | 18.6% | 17.1% |
| EBITDAR | 223 | 403 | 880 | 1,305 | 1,398 |
| EBITDAR Margin | 8.3% | 12.4% | 21.3% | 18.6% | 17.1% |
| EBIT Margin | -2.7% | 2.6% | 12.5% | 14.3% | 13.2% |
| Net Profit Margin | 6.4% | 10.9% | 19.8% | 17.0% | 14.7% |
| Operating Expense % of Sales | 83.9% | 63.5% | 54.9% | 58.0% | 59.1% |
| Returns | |||||
| Return on Assets (ROA) | 6.3% | 12.0% | 25.1% | 13.3% | 13.7% |
| Return on Equity (ROE) | 6.7% | 13.7% | 26.8% | 17.8% | 16.5% |
| ROIC [EBIT / Invested Capital] | -2.8% | 3.3% | 22.4% | 11.9% | 12.7% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 4.9% | 9.8% | 5.9% | 22.9% | 15.5% |
| Debt-to-Equity | 0.05x | 0.11x | 0.06x | 0.31x | 0.19x |
| Debt-to-EBITDA | 0.60x | 0.72x | 0.22x | 1.58x | 0.97x |
| Equity-to-Assets | 94.2% | 87.5% | 93.6% | 74.8% | 83.0% |
| Net Debt | 1 | -30 | -733 | 1,730 | 1,215 |
| Cash & Equivalents | 132 | 321 | 926 | 330 | 147 |
| Total Debt | 133 | 291 | 193 | 2,059 | 1,362 |
| Liquidity & working capital | |||||
| Current Ratio | 5.51x | 3.79x | 10.93x | 2.61x | 3.57x |
| Quick Ratio | 5.71x | 2.42x | 8.63x | 2.61x | 3.57x |
| Cash Ratio | 1.66x | 1.72x | 7.62x | 0.89x | 0.55x |
| Total Current Assets | 439 | 709 | 1,328 | 968 | 953 |
| Total Current Liabilities | 80 | 187 | 121 | 371 | 267 |
| Inventory | -16 | 256 | 279 | N/A | N/A |
| Trade Receivables | 73 | 132 | 123 | 215 | 266 |
| Trade Payables | 11 | 78 | 15 | 196 | 115 |
| Net Working Capital | 360 | 522 | 1,206 | 597 | 686 |
| Net Working Capital % of Revenue | 13.5% | 16.1% | 29.2% | 8.5% | 8.4% |
| Trade Working Capital | 46 | 310 | 387 | 20 | 151 |
| Trade Working Capital % of Revenue | 1.7% | 9.5% | 9.4% | 0.3% | 1.8% |
| Change in Trade Working Capital | N/A | 264 | 77 | N/A | 131 |
| Turnover & efficiency | |||||
| Inventory Turnover | -12.75x | 3.05x | 3.52x | N/A | N/A |
| Days Inventory Outstanding (DIO) | -28.6 | 119.7 | 103.7 | N/A | N/A |
| Receivables Turnover | 36.57x | 24.65x | 33.55x | 32.61x | 30.84x |
| Days Sales Outstanding (DSO) | 10.0 | 14.8 | 10.9 | 11.2 | 11.8 |
| Payables Turnover | 18.51x | 9.98x | 67.27x | 8.39x | 16.95x |
| Days Payable Outstanding (DPO) | 19.7 | 36.6 | 5.4 | 43.5 | 21.5 |
| Cash Conversion Cycle | -38.4 days | 97.9 days | 109.1 days | -32.3 days | -9.7 days |
| Asset Turnover | 0.98x | 1.10x | 1.27x | 0.78x | 0.94x |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →